Profile
YCBD ZTS TAK HLN TEVA VTRS
Company Name cbdMD, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $9.91M $56.15B $54.43B $47.18B $39.78B $14.94B
Employees 0.04K 13.80K 49.28K 24.56K 37.00K 32.00K
CEO T. Ronan Kennedy Kristin C. Peck Christophe Weber Brian James McNamara Richard D. Francis Scott Andrew Smith
Ratings
YCBD ZTS TAK HLN TEVA VTRS
Quant Rating Score 2 3 3 4 3 2
Quant Rating Sell Neutral Neutral Buy Neutral Sell
Trading
YCBD ZTS TAK HLN TEVA VTRS
Last Close $0.602 $118.8 $14.14 $9.68 $24.59 $10.66
High 52 $1.48 $178.71 $15.52 $11.41 $25.83 $13.37
Low 52 $0.13 $118.8 $12.89 $8.73 $12.82 $7.26
Price vs. 52 Week High -59.32 % -33.52 % -8.89 % -15.16 % -4.8 % -20.27 %
Price vs. 52 Week Low 363.08 % 0 % 9.7 % 10.88 % 91.81 % 46.83 %
Total Return
YCBD ZTS TAK HLN TEVA VTRS
1 Month Return -47.65 % -17.53 % 0.71 % 2.11 % 27.34 % 4.82 %
3 Month Return -11.47 % -21.96 % -6.73 % -0.05 % 36.16 % 0.28 %
6 Month Return -36.63 % -27.13 % 0.21 % -10.37 % 45.16 % 20.59 %
9 Month Return 29.18 % -24.08 % 1.73 % -3.1 % 48.4 % -1.84 %
YTD Return 60.53 % -27.09 % 6.8 % 1.47 % 11.57 % -14.38 %
1 Year Return 33.72 % -32.33 % 3.82 % 2.11 % 46.28 % -18.31 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
YCBD ZTS TAK HLN TEVA VTRS
Dividend Yield Percentage (TTM) - 1.59 % 3.78 % 1.46 % - 3.7 %
Dividend Paid and Capex Coverage Ration (TTM) -2.83 % 1.89 % 2.23 % 2.01 % 4 % 2.09 %
Dividend Per Share (TTM) - 2.03 % 198 % 0.06 % - 0.48 %
Payout Ratio (TTM) - 32.55 % 277.04 % 27.27 % - -15.34 %
Profitability
YCBD ZTS TAK HLN TEVA VTRS
Gross Profit Margin TTM 56.5 % 70.63 % 56.31 % 61.81 % 51.76 % 36.07 %
Return on Assets TTM -29.19 % 17.49 % 0.73 % 4.78 % 3.48 % -9.73 %
Return on Equity TTM -77.08 % 53.56 % 1.58 % 9.4 % 20.09 % -22.69 %
Return on Capital Employed TTM -29.93 % 26.48 % 3.76 % 8.34 % 11.54 % -8.43 %
Net Income Per EBT TTM 149.02 % 79.59 % 54.99 % 76.52 % 114.62 % 95.92 %
EBT Per Ebit TTM 94.37 % 94.2 % 42.72 % 88.09 % 39.3 % 149.32 %
EBIT Per Revenue TTM -11.27 % 37.63 % 10.77 % 20.49 % 18.15 % -18.25 %
Cash Flow To Debt Ratio TTM -65323.16 % 40.09 % 23.13 % 12.02 % 11.62 % 13.47 %
Receivables Turnover TTM 18.44 6.1 5.89 5.14 4.68 3.94
Payables Turnover TTM 7.11 6.73 4.17 1.18 3.31 6.81
Inventory Turnover TTM 3.06 1.12 1.39 3.72 2.63 2.2
Fixed Asset Turnover TTM 1838.13 % 241.44 % 214.23 % 589.57 % 392.13 % 488.38 %
Asset Turnover TTM 184.17 % 61.99 % 28.97 % 34.62 % 42.58 % 37.25 %
Operating Cash Flow Per Share TTM -57.01 6.58 710.55 0.11 1.76 1.7
Free Cash Flow Per Share TTM -77.19 5.06 589.53 0.1 1.32 1.37
Cash Per Share TTM 25.36 % 470.54 % 48236.45 % 7.46 % 309.55 % 99.36 %
Operating Cash Flow Sales Ratio TTM -2649.08 % 31.03 % 25.14 % 9.32 % 11.64 % 14.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 135.39 % 76.82 % 82.97 % 90.65 % 74.99 % 80.65 %
Cash Flow Coverage Ratios TTM -65323.16 % 40.09 % 23.13 % 12.02 % 11.62 % 13.47 %
Price To Free Cash Flows Ratio TTM -0.01 25.07 8.89 36.72 26.3 9.34
Price To Operating Cash Flows Ratio TTM -0.02 19.35 7.38 33.85 19.76 7.62
Price Cash Flow Ratio TTM -0.02 19.35 7.38 33.85 19.76 7.62
Income Statement (TTM)
YCBD ZTS TAK HLN TEVA VTRS
Revenue $0.02B $9.26B $4581.55B $11.23B $17.26B $14.74B
Gross Profit $0.01B $6.4B $3001.33B $6.95B $8.94B $5.62B
Gross Profit Ratio 56.5% 69.1% 65.51% 61.85% 51.79% 38.15%
EBITDA $-0B $3.87B $1210.51B $2.51B $3.14B $2.82B
Net Income $-0B $2.49B $107.93B $1.44B $1.41B $-0.63B
EPS Diluted -1.09 5.47 33.62 0.32 1.2 -0.53
Balance Sheet (MRQ)
YCBD ZTS TAK HLN TEVA VTRS
Long Term Debt $0B $5.39B $3966.33B $8.62B $15.56B $14.22B
Total Liabilities $0B $9.47B $7312.37B $18.09B $32.83B $22.87B
Total Equity $0.01B $4.77B $6935.98B $16.22B $7.91B $18.64B
Total Investments $0B $0.03B $382.4B $0.14B $0B $1.7B
Total Debt $0.78B $6.74B $4515.27B $10.1B $17.38B $14.31B
Total Assets $0.01B $14.24B $14248.34B $34.32B $40.75B $41.5B
Cash Flow Statement (TTM)
YCBD ZTS TAK HLN TEVA VTRS
Net Income $-2.04B $2.5B $107.93B $1.44B $1.42B $-0.63B
Inventory $-0B $-0.04B $-34.97B $0.22B $0.15B $-0.72B
Dividends Paid $0B $-0.79B $-302.5B $-0.57B $0B $-0.57B
Operating Cash Flow $-0B $2.95B $1057.18B $2.3B $1.65B $2.3B
Capital Expenditure $-0.18B $-0.66B $-200.8B $-0.25B $-0.5B $-0.33B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.48
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.96
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 5.12
ALVOW Alvotech 0.4511
AMPH Amphastar Pharmaceuticals, Inc. 29.26
AMRX Amneal Pharmaceuticals, Inc. 14.52
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 81.84
APUS Apimeds Pharmaceuticals US, Inc 1.62
AQST Aquestive Therapeutics, Inc. 4.11
ASRT Assertio Holdings, Inc. 12.74
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.69
ETFs With Exposure to YCBD
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 340.96
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 151.14
VXF Vanguard Extended Market Index Fund 0.00008 217.96
THCX The Cannabis ETF 1.83 16.5963
POTX Global X Cannabis ETF 0.02 5.15
TOKE Cambria Cannabis ETF 1.56 5.855
CNBS Amplify Growth Opportunities ETF 0 25.41
YOLO AdvisorShares Pure Cannabis ETF 0.02 2.95
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00008 165.43
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00008 165.44
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKL iShares Morningstar Small-Cap Value ETF 0 172.726
VEMPX Vanguard Extended Market Index InstlPlus 0.00008 408.25
Unlock